BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Lightlake Therapeutics Inc. 



London      United Kingdom
Phone: n/a Fax:


SEARCH JOBS










 Company News
Lightlake Therapeutics Inc. (LLTP), Adapt Pharma Forge Deal Worth $55 Million 12/16/2014 9:17:03 AM
Lightlake Therapeutics Inc. (LLTP) Commences Trial For Treatment Of Opioid Overdose With The U.S. National Institute On Drug Abuse (NIDA) 12/4/2014 11:04:21 AM
Lightlake Therapeutics Inc. (LLTP) Announces Closing Of Investments In Two Products 10/2/2014 9:19:22 AM
Lightlake Therapeutics Inc. (LLTP) Receives Funding Commitment From A Prominent International Research And Development Foundation 7/30/2014 8:31:26 AM
Lightlake Therapeutics Inc. (LLTP) Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 7/23/2014 12:00:10 PM
Lightlake Therapeutics Inc. (LLTP) Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment 7/9/2014 9:54:15 AM
Lightlake Therapeutics Inc. (LLTP) To Present At The Third Annual Marcum MicroCap Conference 5/22/2014 7:08:49 AM
Lightlake Therapeutics Inc. (LLTP) Chief Executive Officer Letter To Shareholders 12/20/2013 11:59:41 AM
Initial Data From Lightlake Therapeutics Inc. (LLTP) Joint Clinical Trial With National Institute on Drug Abuse (NIDA) Shows Nasal Delivery Of Naloxone For Opioid Overdose As A Promising Treatment 12/4/2013 11:10:42 AM
Lightlake Therapeutics Inc. (LLTP) To Present At 6th Annual LD MICRO Conference 11/20/2013 7:30:15 AM
1234